Who Truly Benefits from Anti-EGFR Rechallenge in Metastatic Colorectal Cancer? From Clinical Enrichment to ctDNA-Guided Molecular Hyperselection

Journal of Gastrointestinal Cancer · Published 2026-06-04 · DOI 10.1007/s12029-026-01510-1

Authors (2)

Tamotsu Sagawa, Koshi Fujikawa

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Sagawa, T., Fujikawa, K. (2026). Who Truly Benefits from Anti-EGFR Rechallenge in Metastatic Colorectal Cancer? From Clinical Enrichment to ctDNA-Guided Molecular Hyperselection. Journal of Gastrointestinal Cancer. https://doi.org/10.1007/s12029-026-01510-1

Related articles